Disseminated herpes zoster following treatment with benralizumab

ConclusionClinical trials have reported an association of mepolizumab, another anti ‐IL‐5 monoclonal antibody with herpes zoster. This report of herpes zoster following initiation of benralizumab might suggest a possibility of a class effect of anti‐IL‐5 monoclonal antibody.This article is protected by copyright. All rights reserved.

Source: The Clinical Respiratory Journal - January 21, 2019 Category: Respiratory Medicine Authors: Ajay Kumar Mishra, Kamal Kant Sahu, James Atem Tags: Brief Report Source Type: research